|
Mechanism of atherosclerosis/growth factors
Citations 301-310 of 727 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Critical Role of Macrophage 12/15-Lipoxygenase for Atherosclerosis in Apolipoprotein E-Deficient Mice
- Yuqing Huo, Lei Zhao, Matthew Craig Hyman, Pavel Shashkin, Brian L. Harry, Tracy Burcin, S. Bradley Forlow, Matthew A. Stark, David F. Smith, Sean Clarke, Suseela Srinivasan, Catherine C. Hedrick, Domenico Praticò, Joseph L. Witztum, Jerry L. Nadler, Colin D. Funk, and Klaus Ley
Circulation published September 27, 2004, doi:10.1161/01.CIR.0000143628.37680.F6
[Abstract]
- Articles
Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta. Implications for Plaque Vulnerability
- Pedro R. Moreno, K. Raman Purushothaman, Valentin Fuster, Dario Echeverri, Helena Truszczynska, Samin K. Sharma, Juan J. Badimon, and William N. O’Connor
Circulation published September 27, 2004, doi:10.1161/01.CIR.0000143233.87854.23
[Abstract]
- Articles
Genetically Determined Resistance to Collagenase Action Augments Interstitial Collagen Accumulation in Atherosclerotic Plaques
- Yoshihiro Fukumoto, Jun-o Deguchi, Peter Libby, Elena Rabkin-Aikawa, Yasuhiko Sakata, Michael T. Chin, Christopher C. Hill, Patrick R. Lawler, Nerea Varo, Frederick J. Schoen, Stephen M. Krane, and Masanori Aikawa
Circulation published September 27, 2004, doi:10.1161/01.CIR.0000143174.41810.10
[Abstract]
- Vascular Medicine
Estrogen Modulates Inflammatory Mediator Expression and Neutrophil Chemotaxis in Injured Arteries
- Andrew P. Miller, Wenguang Feng, Dongqi Xing, Nathaniel M. Weathington, J. Edwin Blalock, Yiu-Fai Chen, and Suzanne Oparil
Circulation 2004;110:1664-1669; published online before print as doi:10.1161/01.CIR.0000142050.19488.C7
[Abstract]
[Full text]
- Vascular Medicine
Interleukin-1 Receptor Signaling Mediates Atherosclerosis Associated With Bacterial Exposure and/or a High-Fat Diet in a Murine Apolipoprotein E Heterozygote Model: Pharmacotherapeutic Implications
- Hunghui Chi, Emmanuel Messas, Robert A. Levine, Dana T. Graves, and Salomon Amar
Circulation 2004;110:1678-1685; published online before print as doi:10.1161/01.CIR.0000142085.39015.31
[Abstract]
[Full text]
- Coronary Heart Disease
High-Dose Atorvastatin Reduces Total Plasma Levels of Oxidized Phospholipids and Immune Complexes Present on Apolipoprotein B-100 in Patients With Acute Coronary Syndromes in the MIRACL Trial
- Sotirios Tsimikas, Joseph L. Witztum, Elizabeth R. Miller, William J. Sasiela, Michael Szarek, Anders G. Olsson, Gregory G. Schwartz for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators
Circulation 2004;110:1406-1412; published online before print as doi:10.1161/01.CIR.0000141728.23033.B5
[Abstract]
[Full text]
- Articles
Red Wine Polyphenolic Compounds Strongly Inhibit Pro-Matrix Metalloproteinase-2 Expression and Its Activation in Response to Thrombin via Direct Inhibition of Membrane Type 1-Matrix Metalloproteinase in Vascular Smooth Muscle Cells
- Min-Ho Oak, Jasser El Bedoui, Patrick Anglard, and Valérie B. Schini-Kerth
Circulation published September 13, 2004, doi:10.1161/01.CIR.0000142617.52881.F4
[Abstract]
- Articles
Interleukin-1 Receptor Signaling Mediates Atherosclerosis Associated With Bacterial Exposure and/or a High-Fat Diet in a Murine Apolipoprotein E Heterozygote Model. Pharmacotherapeutic Implications
- Hunghui Chi, Emmanuel Messas, Robert A. Levine, Dana T. Graves, and Salomon Amar
Circulation published September 7, 2004, doi:10.1161/01.CIR.0000142085.39015.31
[Abstract]
- Articles
Estrogen Modulates Inflammatory Mediator Expression and Neutrophil Chemotaxis in Injured Arteries
- Andrew P. Miller, Wenguang Feng, Dongqi Xing, Nathaniel M. Weathington, J. Edwin Blalock, Yiu-Fai Chen, and Suzanne Oparil
Circulation published September 7, 2004, doi:10.1161/01.CIR.0000142050.19488.C7
[Abstract]
- Articles
High-Dose Atorvastatin Reduces Total Plasma Levels of Oxidized Phospholipids and Immune Complexes Present on Apolipoprotein B-100 in Patients With Acute Coronary Syndromes in the MIRACL Trial
- Sotirios Tsimikas, Joseph L. Witztum, Elizabeth R. Miller, William J. Sasiela, Michael Szarek, Anders G. Olsson, Gregory G. Schwartz for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
Circulation published September 7, 2004, doi:10.1161/01.CIR.0000141728.23033.B5
[Abstract]
|
|
